New Delhi: Suraksha Diagnostic IPO closed for subscription on November 3, 2024 (Tuesday). It was subscribed 1.26 times. As per the data available, the portion allocated for retail individual investors received 0.93 subscription. The non-institutional category received 1.40 per cent subscription and 1.4 times in QIB portion.
Suraksha Clinic and Diagnostic which aims to raise Rs 846.25 crore through the IPO route has set the price band in the range of Rs 420 to Rs 441 per equity share. The initial public offer (IPO) of Suraksha Diagnostic is completely an offer-for-sale (OFS) of 1.92 crore shares. The company will not be eligible to receive any proceeds from the IPO and the entire funds will go to the selling shareholders.
Maximum Bid Quantity for Qualified Institutional Investors: 13432516
Maximum Bid Quantity for Non-Institutional Investors: 9594644
Suraksha Clinic and Diagnostic IPO GMP
The Suraksha Clinic and Diagnostics IPO is yet to create any movement in the grey market. The Suraksha Diagnostic IPO GMP is Nil, which indicates that the stock might list on the bourses at par with the issue price. It may be noted that the grey market prices are not official figures.
Book Running Lead Manager of Suraksha Diagnostic IPO: ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited. KFin Technologies Limited is the registrar of the issue.
Suraksha Diagnostic IPO allotment and listing
Suraksha Diagnostic IPO allotment is expected to take place on December 4. The shares will list on NSE and BSE with a tentative date December 6. The process for initiation of refunds is likely to take place on December 5. The shares are expected to be credited to the demat accounts of eligible shareholders on 5th December.
Suraksha Diagnostic mobilised Rs 254 crore from anchor investors. Under the OFS, promoters Ritu Mittal, Satish Kumar Verma and Somnath Chatterjee, and investors OrbiMed Asia II Mauritius Ltd, Munna Lal Kejriwal, and Santosh Kumar Kejriwal will offload shares.
The Kolkata-headquartered Suraksha Diagnostic is engaged in the business of offering a one-stop integrated solution for pathology and radiology testing and medical consultation services to its customers.
The company has a central reference laboratory, eight satellite laboratories and 194 customer touchpoints which include 48 diagnostic centres, and 146 sample collection centres (primarily franchised), across West Bengal, Bihar, Assam, and Meghalaya as of March 31, 2024.
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds.)
Suraksha Diagnostic IPO which closed on November 3, 2024 got 1.26 times subscription. The Suraksha GMP indicated that the shares are expected to have a muted listing on BSE and NSE. Markets Business News – Personal Finance News, Share Market News, BSE/NSE News, Stock Exchange News Today
